The transmission of Sexually Transmitted Infections (STIs) depends upon the number of sexual partners, the number of concurrent partners and the coital frequency . A recent special edition of the Lancet highlighted the importance of STIs, with an estimated 11 transmissions per second, and the challenges of STI control globally . STI transmission between individuals depends upon their position in the sexual network: Commercial Sex Workers (CSWs) have the potential to spread infections to multiple Men who Pay for Sex (MPS) who in turn can further spread or ‘bridge’ these infections to subsequent sexual partners in lower risk sexual networks . Since the majority of STI infections do not lead to noticeable symptoms, the unwitting transmission of infections to and from MPS has the potential to drive epidemics and studies have shown a higher rate of STIs in MPS [4, 5].
The paper by Rich et at in this journal  has looked at the number of men attending open access sexual health services in Israel over 7 years and found that 27% were MPS. This group of men reported more at-risk behaviours such as increased partner number, drug taking and a history of STI diagnoses than the men that did not pay for sex; however, in this analysis no additional STI diagnoses were made in MPS.
Across the World commercial sex work provides convenient sexual intimacy and Israel, like many nations, is grappling with the best way to legislate an industry that is associated with exploitation . The CSWs can play an important public health role and the effective implementation of prevention strategies in this group has the potential to reduce the transmission of infections. Table 1 highlights a range of proven tools that reduce STI transmission during penetrative sex and CSWs should be supported to access and use all of them in their work.
Shows the prevention strategies that have been developed to protect against sexually transmitted infections and their effectiveness
Sexually Transmitted Infection
Non-viral infections (Chlamydia trachomatis/Neisseria gonorrhoea/Trichomonas vaginalis/Mycoplasma genitalium/Ureaplasma urealyticum/Treponema pallidum)
•90% effective with perfect use 
•Testing for STIs and treating when necessary
•100% effective unless there is poor adherence to treatment, reinfection or drug resistance
•Reducing onward transmission, reinfection and the cost to make an STI diagnosis 
Human papilloma virus (HPV)
•Up to 50% 
Hepatitis A virus (HAV)
•Hepatitis A vaccination
Hepatitis B virus (HBV)
•Hepatitis B vaccination
• > 90% 
Herpes virus (HSV 1 & 2)
Human Immunodeficiency Virus (HIV)
•Treatment as prevention
•Preexposure prophylaxis (PrEP)
• > 90% 
Prevention of Human Papilloma, Hepatitis A & B Viruses with vaccination and Human Immunodeficiency Virus (HIV) with Pre-exposure prophylaxis ensures that the risk of acquisition and then onward transmission from a CSW would be negligible. Similarly, if the CSW is already HIV positive, then treatment as prevention would stop onward transmission of the virus to MPS. The role of condoms to prevent bacterial and parasitic infections is still key as a public health intervention and CSWs need to be supported to use them for vaginal, anal and oral sex.
The biggest burden of poor sexual health in the future will come from non-viral infections and drug resistance is a growing challenge within these organisms . Regular STI testing of ‘at risk’ individuals is important to identify infections within a sexual network and this needs to be complemented with effective partner notification to limit onward spread of these infections.
Finally, a history of sex with CSWs was not shown to be associated with acquisition of an STI in one Israeli clinic over 7 years. It is likely that the use of condoms played a pivotal role in this outcome and the high prevalence of circumcision within the men in this study is likely to have contributed too . It is important to build upon these results and focus on CSW access to the prevention methods cited in the table as well as address prejudice against CSWs and their clients .
There are a number of proven prevention tools for STI epidemics. The challenge is to ensure that patient education, staff training, and health care policy initiatives focus on the full use of prevention tools to improve the publics’ health.
I would like to thank the editors of IJHPR for the opportunity to write this commentary.
Ethics approval and consent to participate
Consent for publication
Given by the sole author submitting this work.
The author declares that he/she has no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.